The role that biomarkers can play in asthma control by effectively measuring lung inflammation is a topic that has begun to get more attention lately in medical journals. Although use of most biomarkers is not clinically pragmatic for physicians yet, guest Dr. Stanley Fineman, clinical associate professor in the Department of Pediatrics at Emory University School of Medicine, predicts that biomarkers will likely play a more significant role in the future. Host Dr. Ketan Sheth asks, what other methods are most effective for monitoring control in asthma?